Report Detail
Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Insights and Forecast to 2026
- RnM4171974 |
- 28 August, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Medical Devices & Consumables
Benign Prostatic Hyperplasia (BPH) Treatment Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Benign Prostatic Hyperplasia (BPH) Treatment Devices market is segmented into
Laser Based Procedure
Other Energy Based Procedure
Segment by Application, the Benign Prostatic Hyperplasia (BPH) Treatment Devices market is segmented into
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Other
Regional and Country-level Analysis
The Benign Prostatic Hyperplasia (BPH) Treatment Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the Benign Prostatic Hyperplasia (BPH) Treatment Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share Analysis
Benign Prostatic Hyperplasia (BPH) Treatment Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Benign Prostatic Hyperplasia (BPH) Treatment Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Benign Prostatic Hyperplasia (BPH) Treatment Devices business, the date to enter into the Benign Prostatic Hyperplasia (BPH) Treatment Devices market, Benign Prostatic Hyperplasia (BPH) Treatment Devices product introduction, recent developments, etc.
The major vendors covered:
Endo International (US)
Karl Storz (Germany)
Medtronic (US)
Siemens (Germany)
Lumenis (Israel)
Olympus (Japan)
Urologix (US)
NeoTract (US)
Boston Scientific (US)
Urotech (Germany)
Toshiba (Japan)
Baxter International (US)
1 Study Coverage
- 1.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Growth Rate by Type
- 1.4.2 Laser Based Procedure
- 1.4.3 Other Energy Based Procedure
- 1.5 Market by Application
- 1.5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Ambulatory Surgical Centers
- 1.5.4 Specialty Clinics
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size, Estimates and Forecasts
- 2.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Estimates and Forecasts 2015-2026
- 2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Geographical Distribution
- 2.4 Key Trends for Benign Prostatic Hyperplasia (BPH) Treatment Devices Markets & Products
- 2.5 Primary Interviews with Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers by Production Capacity
- 3.1.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Market Share by Production
- 3.2 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers by Revenue
- 3.2.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue in 2019
- 3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Production by Regions
- 4.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Regions by Production (2015-2020)
- 4.1.2 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (2015-2020)
- 4.2.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (2015-2020)
- 4.3.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (2015-2020)
- 4.4.2 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Benign Prostatic Hyperplasia (BPH) Treatment Devices Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Production (2015-2020)
- 4.5.2 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Import & Export (2015-2020)
5 Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Region
- 5.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Regions by Consumption
- 5.1.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Regions by Consumption (2015-2020)
- 5.1.2 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Application
- 5.2.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Application
- 5.3.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Application
- 5.4.2 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Application
- 5.5.2 Central & South America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Application
- 5.6.2 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Type (2015-2020)
- 6.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production by Type (2015-2020)
- 6.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Type (2015-2020)
- 6.1.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Price by Type (2015-2020)
- 6.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast by Type (2021-2026)
- 6.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Forecast by Type (2021-2026)
- 6.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Price Forecast by Type (2021-2026)
- 6.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 Endo International (US)
- 8.1.1 Endo International (US) Corporation Information
- 8.1.2 Endo International (US) Overview
- 8.1.3 Endo International (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 Endo International (US) Product Description
- 8.1.5 Endo International (US) Related Developments
- 8.2 Karl Storz (Germany)
- 8.2.1 Karl Storz (Germany) Corporation Information
- 8.2.2 Karl Storz (Germany) Overview
- 8.2.3 Karl Storz (Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 Karl Storz (Germany) Product Description
- 8.2.5 Karl Storz (Germany) Related Developments
- 8.3 Medtronic (US)
- 8.3.1 Medtronic (US) Corporation Information
- 8.3.2 Medtronic (US) Overview
- 8.3.3 Medtronic (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 Medtronic (US) Product Description
- 8.3.5 Medtronic (US) Related Developments
- 8.4 Siemens (Germany)
- 8.4.1 Siemens (Germany) Corporation Information
- 8.4.2 Siemens (Germany) Overview
- 8.4.3 Siemens (Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 Siemens (Germany) Product Description
- 8.4.5 Siemens (Germany) Related Developments
- 8.5 Lumenis (Israel)
- 8.5.1 Lumenis (Israel) Corporation Information
- 8.5.2 Lumenis (Israel) Overview
- 8.5.3 Lumenis (Israel) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Lumenis (Israel) Product Description
- 8.5.5 Lumenis (Israel) Related Developments
- 8.6 Olympus (Japan)
- 8.6.1 Olympus (Japan) Corporation Information
- 8.6.2 Olympus (Japan) Overview
- 8.6.3 Olympus (Japan) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 Olympus (Japan) Product Description
- 8.6.5 Olympus (Japan) Related Developments
- 8.7 Urologix (US)
- 8.7.1 Urologix (US) Corporation Information
- 8.7.2 Urologix (US) Overview
- 8.7.3 Urologix (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 Urologix (US) Product Description
- 8.7.5 Urologix (US) Related Developments
- 8.8 NeoTract (US)
- 8.8.1 NeoTract (US) Corporation Information
- 8.8.2 NeoTract (US) Overview
- 8.8.3 NeoTract (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 NeoTract (US) Product Description
- 8.8.5 NeoTract (US) Related Developments
- 8.9 Boston Scientific (US)
- 8.9.1 Boston Scientific (US) Corporation Information
- 8.9.2 Boston Scientific (US) Overview
- 8.9.3 Boston Scientific (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 Boston Scientific (US) Product Description
- 8.9.5 Boston Scientific (US) Related Developments
- 8.10 Urotech (Germany)
- 8.10.1 Urotech (Germany) Corporation Information
- 8.10.2 Urotech (Germany) Overview
- 8.10.3 Urotech (Germany) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.10.4 Urotech (Germany) Product Description
- 8.10.5 Urotech (Germany) Related Developments
- 8.11 Toshiba (Japan)
- 8.11.1 Toshiba (Japan) Corporation Information
- 8.11.2 Toshiba (Japan) Overview
- 8.11.3 Toshiba (Japan) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.11.4 Toshiba (Japan) Product Description
- 8.11.5 Toshiba (Japan) Related Developments
- 8.12 Baxter International (US)
- 8.12.1 Baxter International (US) Corporation Information
- 8.12.2 Baxter International (US) Overview
- 8.12.3 Baxter International (US) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.12.4 Baxter International (US) Product Description
- 8.12.5 Baxter International (US) Related Developments
9 Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Forecast by Regions
- 9.1 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Benign Prostatic Hyperplasia (BPH) Treatment Devices Regions Forecast by Production (2021-2026)
- 9.3 Key Benign Prostatic Hyperplasia (BPH) Treatment Devices Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Region
- 10.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Region (2021-2026)
- 10.2 North America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Region (2021-2026)
- 10.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Channels
- 11.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors
- 11.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry
- 12.2 Market Trends
- 12.3 Market Opportunities and Drivers
- 12.4 Market Challenges
- 12.5 Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Risks/Restraints
- 12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Benign Prostatic Hyperplasia (BPH) Treatment Devices. Industry analysis & Market Report on Benign Prostatic Hyperplasia (BPH) Treatment Devices is a syndicated market report, published as Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
